DOCSLIB.ORG

Immuno Logy 2015 ™ Pr Ogram Preview Issue

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immuno Logy 2015 ™ Pr Ogram Preview Issue THE journal journal Discover PE/Dazzle™ 594 OF Immunology Th eJournal of Immunology VOL. 194 VOL. VOLUME 194, NUMBER 6 • MARCH 15, 2015 • WWW.JIMMUNOL.ORG | NO. 6 NO. | March 15, 2015 | Pages 2451–2956 Pages PE/Dazzle™ 594 PE/Dazzle™ 594 PE-eFluor ® 610 Antibody Conjugates CD56 CD56 BioLegend is proud to unveil PE/Dazzle™ 594, our newest tandem fl uorophore for multicolor fl ow cytometry. PE/Dazzle™ 594 can be excited by the blue (488 nm), green (532 nm) or yellow/green lasers (561 nm), and is detected in the PE-Texas Red® channel. CD3 FITC CD3 FITC BD Horizon™ PE-CF594 PE/Dazzle™ 594 off ers: Human peripheral blood lymphocytes were • Outstanding brightness • Exceptional photostability stained with FITC anti- human CD3 and anti- • Lower compensation • Excellent pricing human CD56 conjugated CD56 requirements compared to • Multicolor panel design to either PE/Dazzle™ 594 spectrally equivalent fl uorophores or other companies’ fl exibility equivalent fl uorophore. CD3 FITC Stay current on all the PE/ Dazzle™ 594 products and request Texas Red® is a registered trademark of Life Technologies Corporation. custom conjugates at: biolegend.com/PE-Dazzle594 BD Horizon™ is a trademark of Becton, Dickinson and Company ™ eFluor® is a registered trademark of eBioscience. BioLegend is ISO 9001:2008 and ISO 13485:2003 Certifi ed Toll-Free Tel: (US & Canada): 1.877.BIOLEGEND (246.5343) Tel: 858.768.5800 biolegend.com 08-0044-07 IMMUNOLOGY 2015 World-Class Quality | Superior Customer Support | Outstanding Value PROGRAM PREVIEW ISSUE IMMUNOLOGY 2015™ PROGRAM PREVIEW The American Association of Immunologists AAI Annual Meeting May 8–12, 2015 | New Orleans, LA Ernest N. Morial Convention Center The American Association of Immunologists Career Award Recipients for 2015 The American Association of Immunologists proudly announces the 2015 recipients of AAI awards for outstanding research and career achievements. The 2015 AAI award winners will be recognized at IMMUNOLOGY 2015™ May 8–12, New Orleans, Louisiana. AAI Lifetime AAI Distinguished Achievement Award Service Award In recognition of a career For outstanding service to AAI of scientific achievement and and the immunology community contributions to AAI and as member and Chair of the fellow immunologists AAI Committee on Public Affairs, 2007–2014 Jonathan Sprent, M.B.B.S., Ph.D. Elizabeth J. Kovacs, Ph.D. Garvan Institute of Medical Research Loyola University Chicago Stritch School of Medicine AAI-Steinman Award for AAI-BioLegend AAI-Thermo Fisher Human Immunology Research Herzenberg Award Meritorious Career Award For significant, For outstanding For outstanding sustained research research achievement in contributions contributions immunology to the field to the field research pertinent of immunology of immunology to human disease pathogenesis, in the area prevention, or of B cell biology therapy Ronald N. Germain, M.D., Ph.D. Mary Ellen Conley, M.D. Matthew D. Scharff, M.D. National Institute of Allergy and Rockefeller University Albert Einstein College of Medicine Infectious Diseases, National Institutes of Health AAI-BD Biosciences AAI Excellence Investigator Award in Mentoring Award For outstanding, early-career In recognition of exemplary research contributions career contributions to a future to the field of immunology generation of scientists Thirumala-Devi Kanneganti, Ph.D. Rafi Ahmed, Ph.D. St. Jude Children’s Research Hospital Emory University School of Medicine www.IMMUNOLOGY2015.org PROGRAM PREVIEW IMMUNOLOGY 2015™ AAI PRESIDENT’S PROGRAM AAI President’s Address FRIDAY, MAY 8, 5:00 PM Ernest N. Morial Convention Center, The Great Hall Linda A. Sherman Scripps Research Institute, AAI President Using Autoimmunity to Inform Tumor Immunity Steven J. Burakoff, The Tisch Cancer Institute Linda A. Sherman Introduction AAI President’s Symposium: Partners in Crime and T Cell Sleuths MONDAY, MAY 11, 12:30 PM – 2:30 PM The Great Hall Chair: Linda A. Sherman, Scripps Research Institute, AAI President Speakers: Matthew F. William R. Heath Matthew F. Mescher, University of Minnesota Mescher Programming of naive CD8 T cells to develop function and memory William R. Heath, University of Melbourne Tissue-resident memory in viral and parasite immunity Linda S. Wicker, University of Cambridge From autoimmune disease genetics to immune-based therapies Charles D. Surh, Academy of Immunology and Microbiology, Institute for Basic Science, Pohang, Korea Regulation of immune homeostasis to commensal bacterial Linda S. Wicker Charles D. Surh and dietary antigens IMMUNOLOGY 2015™ | THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS AAI President’s Symposium purifying MHC molecules. Together, we demonstrated that MHC molecules contained all the information required for induction of a secondary response by alloantigen-specifi c cytolytic T lymphocytes. Of course other information is required for naive T cell activation, such as costimulation as demonstrated by our past AAI president Marc Jenkins. Matt Mescher has been at the forefront of demonstrating the important role of yet a third signal, infl ammatory cytokines, which we will hear about in this symposium. William R. Heath. Years later at The Scripps Research Institute (TSRI), Bill Heath and I further demonstrated that Linda A. Sherman allogeneic MHC molecules contained peptides that were also AAI President required for TCR recognition. Bill, who was a postdoctoral fellow at the time, then went on to a highly successful career hen I fi rst learned that my colleagues had in cellular immunology. Recently, he and his long-term honored me with the privilege of representing collaborator Frank Carbone have turned their attention to them on AAI Council and that one day I would W the importance of tissue-resident T cells in defense against become president of AAI, I thought about how lucky I was pathogens, a fi eld they have helped to pioneer. to have gone into research. Of course, luck played a part in my being accorded this honor, but a larger part was due to Linda S. Wicker. I fi rst met Linda Wicker at a conference the patience of my mentors and the hard work and talent on diabetes when I talked about a new model my lab had of the trainees I have had the privilege to mentor. And then developed for looking at the activation of islet antigen- there are the colleagues with whom I have collaborated over specifi c CD8 T cells in draining lymph nodes of diabetes- the years, each of whom greatly enriched the scope of my prone NOD mice. Linda wrote the book on the genetic basis research, and, importantly, whom I treasure as dear friends. of the development of diabetes in NOD mice and wondered whether our model could be used to dissect the cellular This year’s President’s Symposium takes a slightly different consequences of the genetic polymorphisms that contributed direction from most. Rather than focusing on a single topic, I to disease. This led to some of the most stimulating have focused on the research of several highly accomplished scientifi c conversations I have ever had and to a long-term immunologists who also happen to have been my highly collaboration. Her work on the genetics of type 1 diabetes valued collaborators. If there is a scientifi c link in their and the immunological consequences in mice and humans research, it is that at some point in their careers, our research has led to numerous breakthroughs in the fi eld and, now, to intersected. These are my close collaborators and friends— an immunotherapeutic approach to the disease that we will or, as I call them, my “partners in crime.” I apologize for such hear about in this symposium. self-indulgence, but I considered this opportunity to bring together, in one session, colleagues whom I greatly admire Charles D. Surh. Charlie Surh started as a postdoctoral and respect to be one of the great privileges associated with fellow at TSRI with Jon Sprent and advanced through the my tenure as president of AAI! ranks to become professor. Their talent and ingenuity in the areas of thymic development, tolerance, and homeostasis is Matthew F. Mescher. When I went to Harvard Medical legendary. Recently, Charlie’s research on homeostasis led School to work as a postdoctoral fellow with Steve Burakoff him to South Korea, where he was provided an opportunity and Baruj Benacerraf, I selected a project that was at the to set up his own institute to study the role of gut antigens in very heart of T cell biology and a great mystery at that time, lymphocyte homeostasis and development of the immune the molecular basis for TCR recognition. We knew the MHC system. He has the only mouse colony in the world that has was important, but there was great debate about whether not only germ-free, but also antigen-free mice. This work has other molecules contributed as well. Matthew Mescher was provided a window into the fundamental role of antigen in a newly minted assistant professor who had come from the development of the immune system, a role we will hear Strominger’s lab and wanted to address this question by about in this symposium. www. IMMUNOLOGY2015. org LECTURES2014 AAI AND CAREER AWARD AWARD PRESENTATIONS RECIPIENTS AAI DISTINGUISHED LECTURERS AAI BUSINESS MEETING & AWARDS PRESENTATIONS SATURDAY, MAY 9 SATURDAY, MAY 9, 1:00 PM - 2:30 PM 6:00 PM, THE GREAT HALL AAI reports on the “state of the association” to its members Dennis R. Burton at every AAI annual meeting. Members will hear from the Scripps Research Institute Executive Director, the Secretary-Treasurer, the Editor-in- Broadly neutralizing antibodies Chief of The Journal of Immunology (The JI), and the Chair of evolved to counter the structure the Committee on Public Affairs on the fi nancial standing of and variability of HIV and provide AAI, the status of The JI, important public policy issues, and a basis for vaccine design other items of interest for the membership.
Load more

Recommended publications
  • At FOCIS 2016
    SAVE THE DATE Immunology by the Bay KEYNOTE SPEAKERS: Frank Nestle, MD Lewis Lanier, PhD King's College London University of California, San Francisco IMMUNOTHERAPY From Pathogens to Autoimmunity to Cancer FOCIS 2016 Supporters FOCIS gratefully acknowledges the support that allows FOCIS to fulfill its mission to foster interdisciplinary approaches to both understand and treat immune-based diseases, and ultimately to improve human health through immunology. Platinum Level Sponsors Gold Level Sponsors Silver Level Sponsors Immune Tolerance Network Bronze Level Sponsors Copper Level Sponsors Thank you to the FOCIS 2016 Travel Award Supporters: Dear Colleagues, Welcome to the 16th annual meeting of the Federation of Clinical Immunology Societies, FOCIS 2016. I am partic- ularly excited about this year’s meeting. The scientific program reflects the core tenets of FOCIS by bridging the gap between basic and clinical immunology and discussing novel translational therapies. We value the participation of each of you who have touched FOCIS in one way or another over the past 16 years, and we hope that you will join us as we move into the future. FOCIS introduced individual membership in 2012, and I invite you to join FOCIS and collaborate with us to promote education, research and patient care around the theme of translational immunology. Memberships run on a calendar year basis and are available at reasonable prices. At FOCIS 2016, membership also gains you exclusive access to a Members Only Lounge complete with a complimentary espresso bar as well as a Pushing the hip Members Only Reception in the Lighthouse on Thursday, June 23. boundaries of Please join me in extending my most heartfelt thanks to the members of the FOCIS 2016 Scientific Program Committee for their time, energy and expertise.
    [Show full text]
  • Final Program
    June 25-28, chicago, illinois Spotlight on Translational Immunology Scientific Program Create Your Masterpiece Alexa Fluor® 594 anti-Ki-67 Direct Antibody Conjugates for Multicolor Microscopy For multicolor uorescence microscopy, bright uorescence with little background is critical for speci c detection of antigens. Furthermore, directly labeled antibodies are essential for multicolor microscopy. BioLegend now introduces our line of antibodies directly conjugated to Alexa Fluor® 594, a bright, stable uorophore emitting into the red range of the color spectrum, ideal for imaging applications. Brilliant Violet 421™ is an exceptionally bright and photostable uorescent polymer well- suited for microscopy applications. BioLegend has over 100 IHC HeLa cells were xed, permeabilized, and blocked, then intracellularly stained with Ki-67 (clone Ki-67) Alexa Fluor® 594 (red) and Alexa Fluor® 488 or IF suitable clones conjugated to Brilliant Violet™, Alexa Fluor®, Phalloidin (green). Nuclei were counterstained with DAPI (blue). The image and DyLight®, including secondary antibodies and streptavidin. was captured with 40x objective. Learn more: biolegend.com/AF594 Alexa Fluor® is a trademark of Life Technologies Corporation. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd. biolegend.com/brilliantviolet DyLight® is a trademark of Thermo Fisher Scienti c Inc. and its subsidiaries. BioLegend is ISO 9001:2008 and ISO 13485:2003 Certi ed Toll-Free Tel: (US & Canada): 1.877.BIOLEGEND (246.5343) Tel: 858.768.5800 biolegend.com 08-0040-03 2 World-Class Quality | Superior Customer Support | Outstanding Value 08-0040-03.indd 1 5/13/14 8:54 AM Spotlight on Translational Immunology Dear Colleagues, Welcome to the 14th annual meeting of the Federation of Clinical Immunology Societies, FOCIS 2014.
    [Show full text]
  • The American Association of Immunologists Oral History Project
    The American Association of Immunologists Oral History Project Transcript Rafi Ahmed, Ph.D. May 5, 2015 New Orleans, LA Interview conducted by Brien Williams, Ph.D. Transcription: TechniType Transcripts Transcript copy editors: John S. Emrich, Ph.D., and Charles L. Richter, M.A. Final edit by: John S. Emrich, Ph.D. © 2016 The American Association of Immunologists, Inc. Publicly released transcripts of The American Association of Immunologists, Inc. (AAI) Oral History Project are freely available for non-commercial use according to the Fair Use provisions of the United States Copyright Code and International Copyright Law. Advance written permission is required for reproduction, redistribution, and extensive quotation or excerpting. Permission requests should be made to: The American Association of Immunologists, 1451 Rockville Pike, Suite 650, Rockville, MD 20852. To cite an interview, please use the following general format: [Name of interviewee], interview by [name of interviewer], [date], The American Association of Immunologists Oral History Project. http://www.aai.org/OHP (accessed [date]). Williams: This is an interview with Dr. Rafi Ahmed for the American Association of Immunologists (AAI) Oral History Project. Dr. Ahmed is Director of the Emory Vaccine Center at Emory University. He is also the Charles Howard Candler Professor of Microbiology and Immunology at Emory, and Georgia Research Alliance Eminent Scholar in Vaccine Research, and professor of microbiology and immunology at Emory at the School of Medicine. He was awarded the AAI Excellence in Mentoring Award in 2015. We are at the IMMUNOLOGY 2015™ in New Orleans, Louisiana. Today is Monday, May 11th, and I am Brien Williams. Thank you very much for dropping by.
    [Show full text]
  • A Scientific Dissent from Darwinism
    A SCIENTIFIC DISSENT FROM DARWINISM “We are skeptical of claims for the ability of random mutation and natural selection to account for the complexity of life. Careful examination of the evidence for Darwinian theory should be encouraged.” This was last publicly updated May 2021. Scientists listed by doctoral degree or current position. Philip Skell* Emeritus, Evan Pugh Prof. of Chemistry, Pennsylvania State University Member of the National Academy of Sciences Lyle H. Jensen* Professor Emeritus, Dept. of Biological Structure & Dept. of Biochemistry University of Washington, Fellow AAAS Maciej Giertych Full Professor, Institute of Dendrology Polish Academy of Sciences Lev Beloussov Prof. of Embryology, Honorary Prof., Moscow State University Member, Russian Academy of Natural Sciences Eugene Buff Ph.D. Genetics Institute of Developmental Biology, Russian Academy of Sciences Emil Palecek Prof. of Molecular Biology, Masaryk University; Leading Scientist Inst. of Biophysics, Academy of Sci., Czech Republic K. Mosto Onuoha Shell Professor of Geology & Deputy Vice-Chancellor, Univ. of Nigeria Fellow, Nigerian Academy of Science Ferenc Jeszenszky Former Head of the Center of Research Groups Hungarian Academy of Sciences M.M. Ninan Former President Hindustan Academy of Science, Bangalore University (India) Denis Fesenko Junior Research Fellow, Engelhardt Institute of Molecular Biology Russian Academy of Sciences (Russia) Sergey I. Vdovenko Senior Research Assistant, Department of Fine Organic Synthesis Institute of Bioorganic Chemistry and Petrochemistry Ukrainian National Academy of Sciences (Ukraine) Henry Schaefer Director, Center for Computational Quantum Chemistry University of Georgia Paul Ashby Ph.D. Chemistry Harvard University Israel Hanukoglu Professor of Biochemistry and Molecular Biology Chairman The College of Judea and Samaria (Israel) Alan Linton Emeritus Professor of Bacteriology University of Bristol (UK) Dean Kenyon Emeritus Professor of Biology San Francisco State University David W.
    [Show full text]